Sumitomo Pharma Co., Ltd.
SMDPY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $594,378 | $11,206,000 | $2,415,000 | $53,448,000 |
| Dep. & Amort. | $35,790 | $5,203,000 | $5,807,000 | $6,066,000 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$134,222 | -$7,848,000 | -$733,000 | $183,000 |
| Other Non-Cash | -$370,395 | -$8,562,329 | $3,520,000 | -$58,758,000 |
| Operating Cash Flow | $125,550 | -$1,329 | $11,009,000 | $939,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10,672 | -$1,474,000 | -$2,375,000 | -$2,057,000 |
| Net Acquisitions | $210,065 | -$2,338,000 | $539,000 | -$539,000 |
| Inv. Purchases | -$18,332 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $22,918 | $0 | $0 | $0 |
| Other Inv. Act. | $16,320 | $3,782,143 | $4,147,000 | $2,588,000 |
| Investing Cash Flow | $220,300 | -$29,857 | $2,311,000 | -$8,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$320,576 | -$670,000 | -$28,271,000 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$1,000 | -$1,000 | -$1,000 |
| Other Fin. Act. | -$4,720 | $693,278 | -$35,263,000 | -$15,864,000 |
| Financing Cash Flow | -$325,296 | $22,278 | -$63,535,000 | -$15,865,000 |
| Forex Effect | $98,471 | -$4,076 | $1,110,000 | $117,000 |
| Net Chg. in Cash | $119,025 | -$12,984 | -$62,277,000 | $85,393,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $141,597 | $154,581 | $85,393,000 | $99,082,000 |
| End Cash | $260,622 | $141,597 | $23,116,000 | $85,393,000 |
| Free Cash Flow | $118,364 | -$1,666,000 | $8,634,000 | -$1,118,000 |